Published June 2015 | Version v1
Journal article

Prognostic value of maximum standard uptake value on pretreatment 18F-FDG PET-CT in newly diagnosed extranodal natural killer/T-cell lymphoma

  • 1. Department of Nuclear Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu (China)

Description

Objective: To determine the prognostic value of maximum standard uptake value (SUVmax) on pretreatment 18F-FDG PET-CT scan in patients with newly diagnosed extranodal natural killer/T cell lymphoma (ENKL). Methods: The clinical information of 44 patients with ENKL undergoing 18F-FDG PET-CT scan before treatment were analyzed retrospectively. SUVmax on PET-CT were evaluated by SPSS 17.0 for the associations with prognostic factors, treatment efficacy and survival time. Results: The median SUVmax was significantly higher (Z = -2.660, P = 0.008) in patients with B symptoms (14.8 [3.9-25.7]) than that without B symptoms (9.0 [5.0-18.6]). The SUVmax of patients with hemophagocytic syndrome (15.7 [8.4-25.7]) was also significantly higher (Z = -2.464, P = 0.014) than that without (11.0 [3.9-25.2]). There was no significant difference between patients with and without Epstein-Barr virus infection (Z = -1.171, P=0.242). The SUVmax was positively associated with patient characteristics including Korean prognostic index (r = 0.470, P = 0.001), stage (r = 0.449, P = 0.002), Ki-67 (r = 0.476, P = 0.001), lactate dehydrogenase (r = 0.394, P = 0.010) and β2-microglobulin level (r = 0.398, P = 0.010). The SUVmax was inversely associated with white blood cell count (r = -0.328, P = 0.034) and lymphocyte count (r = -0.315, P = 0.042). There was no association between SUVmax and age, hemoglobin content and platelet count (P > 0.05). The SUVmax was significantly different between complete and incomplete remission (Z = -3.160, P = 0.002), between patients with and without treatment efficacy (Z = -2.998, P = 0.003). The complete remission, overall response and 2-year overall survival rates were significantly different between patients with SUVmax below and above 12.75 (P < 0.05). Conclusion: The SUVmax on pretreatment 18F-FDG PET-CT in patients with ENKL is well correlated with other prognostic factors and it can be used to predict the prognosis. (authors)

Additional details

Publishing Information

Journal Title
Journal of Diagnostic Imaging and Interventional Radiology
Journal Volume
24
Journal Issue
3
Journal Page Range
p. 242-246
ISSN
1005-8001

Optional Information

Notes
2 figs., 3 tabs., 20 refs.; http://dx.doi.org/10.3969/j.issn.1005-8001.2015.03.015